Dr. Ian Flinn explains in an interview with CURE how Lunsumio VELO (mosunetuzumab) works and its impact on patients with ...

High immune inflammation detected through simple blood tests is tied to a 57% higher risk of depression and a 56% higher risk ...

QUILT-3.055 is a basket trial evaluating nogapendekin alfa inbakicept across multiple solid tumor types. In the NSCLC cohort, patients received the agent via subcutaneous injection every three weeks ...

According to the data on some 990,000 people diagnosed with cancer in 2016 across the country, prostate cancer logged the ...

A major achievement with far-reaching implications for treating deadly skin cancer has been discovered by Tel Aviv University ...

A new clinical study published in the International Journal of Gynecological Cancer reports encouraging results for women ...

The health ministry has released for the first time five-year survival rates for new cancer patients by cancer site that are based on data from Japan's national registry. According to the data on some ...

The Korean American Community Foundation of San Francisco (KACF-SF) announced the awardees of its 2026 Community Grant Program, awarding $400,000 to community-based organizations serving low-income ...

Persistent itching can sometimes signal serious illness, including cancer. Oncologist Dr Amit Garg highlights four ...

According to the IAEA’s latest bulletin, the work focused on clinical applications of biodosimetry — the use of biological responses to estimate the amount of ionising radiation a patient receives.

Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving cell and gene therapies, ...

A study in Ladakh shows soldiers from the plains face higher rates of acne, alopecia, and eczema than natives. Harsh UV and cold stress drive these skin issues, requiring better protective care.